StockStory.org on MSN
LH Q4 deep dive: Specialty testing and hospital partnerships offset volume challenges
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to ...
Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Management View Chad Robins, Co-Founder, CEO & Chairman, highlighted ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
New Lab Volume Index, Highlighting More Trends and Expanded Functionality, Shows Testing Capacity Being Absorbed by Doubling of Demand for Women’s Health, Led by Prenatal Testing New Lab Volume Index, ...
Laboratory Corporation of America Holdingsor LabCorp LH is gaining from an ongoing rebound in the base business across both operating segments. A strong solvency position is an added upside. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results